Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of ALX148, Pembrolizumab, and Chemotherapy for Patients with Advanced Head and Neck Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Setanaxib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of LN-144 and LN-145 (Tumor Infiltrating Lymphocytes) in patients with solid tumors, including melanoma, head and neck cancer, and non-small cell lung cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Pembrolizumab, Epacadostat, and Drug Combination for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials
Not recruiting
Investigated Drugs:
+5
Study on the Safety and Effects of Durvalumab and Tremelimumab with Radiotherapy for Patients with Metastatic Squamous Cell Carcinoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Tislelizumab, Surzebiclimab, and LBL-007 for Patients with Recurrent or Metastatic Head and Neck Cancer
Not recruiting
Investigated Drugs: